Blood cancer treatment may age immune cells as much as 30 years

Researchers, by tracking a molecular marker that has been shown to increase in white blood cells as people age, have uncovered clues that suggest that stem cell transplant is linked to a marked increase in the 'molecular age' of these immune cells in a group of patients with blood cancer.